Ella Therapeutics Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC (NCT04521075) | Ella Therapeutics Ltd | 2020-11-01 |
Track Ella Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.